Malignant progression is orchestrated by USP18, impacting cellular pathways involved in tumor development and growth.
Key evidence shows a significant correlation between USP18 levels and the attenuation of p53 signaling in nasopharyngeal cancer cells.
Assessment using molecular analysis techniques demonstrates the involvement of UBR5 in modulating p53 pathway activity in response to USP18.
The findings suggest that targeting this pathway may offer new therapeutic strategies against nasopharyngeal carcinoma, but further studies are needed.